Arogya Sanjeevani Policy of ManipalCigna Health Insurance, also Covers Coronavirus Treatment

▴ Arogya Sanjeevani Policy of ManipalCigna Health Insurance, also Covers Coronavirus Treatment
Arogya Sanjeevani Policy, ManipalCigna provides affordable all India health coverage also includes cover for modern treatments & procedures; hospitalisation coverage for infectious diseases like Coronavirus (Covid-19)

ManipalCigna Health Insurance Company Limited, a joint venture between Manipal Group, an eminent player in the field of healthcare delivery and higher education, U.S. based global health service leader, Cigna Corporation and Indian conglomerate TTK Group, recently announced the launch of its 'Arogya Sanjeevani Policy, ManipalCigna' in line with IRDAI's issued guidelines for a standard health cover policy. The product is specially designed to ensure that quality healthcare remains accessible and affordable to millions of people in India, especially in times when medical expenses are getting beyond everyone's reach.

'Arogya Sanjeevani Policy, ManipalCigna' is a simplified product that provides an essential health cover of Rs 1 lakh to Rs 5 lakhs for medical treatment of illnesses and injuries requiring in-patient hospitalization including for infectious diseases like Coronavirus (Covid-19) or similar such diseases and also provides cover for listed modern treatments & procedures. In addition, the product offers pre- hospitalization, post-hospitalization, AYUSH treatment, all day-care treatments, road ambulance, cumulative bonus in case of no claim and medical expenses if the insured undergoes a cataract surgery. The product also provides a family discount of 15% for covering 2 and more family members under the single individual policy to make it more affordable for families. There is an additional Online Renewal Discount of 3% p.a. from first renewal onwards, if the premium is received through NACH or Standing Instruction (where payment is made either by direct debit of bank account or credit card).

Speaking about the product launch, Prasun Sikdar, Managing Director and CEO, ManipalCigna Health Insurance Company Limited said, "Considering the growing medical inflation, and the rising infectious diseases like Coronavirus (Covid-19), having a health insurance coverage is a necessity for every individual and family. It's important for us to be prepared in advance and a safety net of health insurance coverage for yourself and family gives us protection against the medical expenses of the future. Our Arogya Sanjeevani, ManipalCigna Policy, could be a good choice for the first-time health insurance buyers in India as the policy is designed to provide access to quality health care while safeguarding your financial well-being."

Hospitalisation is a testing time for all and looking at the soaring healthcare costs, the product covers necessary hospitalization expenses incurred at any medical facility registered with ManipalCigna's network in India and even in non-network hospitals. It also covers the expenses incurred towards - dental treatment or plastic surgery necessitated due to disease or injury. Additionally, the policyholder will be provided a grace period of up to 30 days, for a yearly mode of payment. In case of a free-look period - the insured shall be allowed a period of fifteen days from date of receipt of the policy to review the terms and conditions of the policy, and to return the same if not acceptable.

Tags : #manipalcignahealthinsurance #covid-19treatment #arogyasanjeevanipolicy #moderntreatment

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Cancer on the Menu: How Excess Salt is Quietly Killing Your StomachDecember 03, 2024
Breaking Barriers: Honouring the International Day of Persons with Disabilities December 03, 2024
Invisible Threat: How Air Pollution is Impacting Pregnancies and Shaping Future GenerationsDecember 03, 2024
Medanta Gurugram successfully treats ‘rarest of rare’ lymph node cancer resistant to other drugs using CAR-T Cell TherapyDecember 03, 2024
Nonin Medical secures FDA clearance for its over-the-counter fingertip pulse oximeter, accurate for patients of all skin colorsDecember 02, 2024
ALARM 2024: Amrita Leads the Fight Against Antimicrobial ResistanceDecember 02, 2024
Coral adaptation unlikely to keep pace with global warmingDecember 02, 2024
Reaching the unreached to find missing TB casesDecember 02, 2024
Sip Smart: Why Changing Your Water Habits Can Change Your LifeNovember 28, 2024
Can Your Fingers Predict How Much You Drink? New Study ExplainsNovember 28, 2024
India Leads Global Medical Tourism with 8% Share; PSRI Sets New Benchmarks with nearly 15% International Patient BaseNovember 28, 2024
Medicines save lives but not when they stop workingNovember 28, 2024
A total of 340 Children Participated in the Painting Competition Organized by Asian HospitalNovember 28, 2024
The Standing Desk Myth: Is Sitting Actually Healthier?November 27, 2024
How Cancer Outsmarts Chemotherapy: The Hidden Metabolic GameNovember 27, 2024
Aakash Healthcare Saves life of a 61-year-old Women through Timely Neuro-intervention with a multi-disciplinary management of StrokeNovember 27, 2024
Breakfast Wars: Why Men and Women Should Eat DifferentlyNovember 27, 2024
Only 10% of Businesses Are Ready to Become Experience-Orchestrated, Highlighting Lack of PersonalisationNovember 27, 2024
Investors Think Safe, but Act Bold: MyFi Report Exposes Risk Tolerance Mismatch November 27, 2024
Indkal Technologies Redefines Luxury Home Entertainment with Acer M Series Hybrid MiniLED TelevisionsNovember 27, 2024